Financials data is unavailable for this security.
Cash flow in CNYView more
In 2023, cash reserves at Shanghai MicuRx Pharmaceutical Co Ltd fell by 13.61m. However, Cash Flow from Investing totalled 334.63m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 329.08m for operations while cash used for financing totalled 19.61m.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.8664 |
---|---|
Tangible book value per share | 0.8637 |
More ▼
Balance sheet in CNYView more
Current ratio | 6.79 |
---|---|
Quick ratio | 6.43 |
Total debt/total equity | 0.5355 |
---|---|
Total debt/total capital | 0.3488 |
More ▼